2023
Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
SVEDMYR, Sven, Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI et. al.Základní údaje
Originální název
Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
Autoři
SVEDMYR, Sven (garant), Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA (203 Česká republika, domácí), Ding ZOU a Ludger GROTE
Vydání
Journal of Sleep Research, HOBOKEN, WILEY, 2023, 0962-1105
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.400 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130273
Organizační jednotka
Lékařská fakulta
UT WoS
000899297400001
Klíčová slova anglicky
antihypertensive treatment; beta-blocker; blood pressure control; diuretic; hypertension; obstructive sleep apnea
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 11. 2023 07:41, Mgr. Tereza Miškechová
Anotace
V originále
We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged males with hypertension. Conversely, the combination of a beta-blocker and a diuretic was associated with lower systolic and diastolic blood pressure in patients with hypertension with moderate-severe OSA. Systolic blood pressure was better controlled in female patients using this combined treatment. Our cross-sectional data suggest that specific clinical characteristics and type of antihypertensive medication influence the degree of blood pressure control in patients with hypertension with OSA. Controlled trials are warranted.